Micafungin Reig Jofre Uk

Micafungin, the active ingredient in Micafungin Reig Jofre Uk, is an echinocandin presented as an intravenous formulation for infusion use. It treats invasive candidiasis, esophageal candidiasis, and is used for prophylaxis of Candida infections in hematopoietic stem cell transplantation. GNH USA supplies Micafungin Reig Jofre Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Micafungin is an echinocandin antifungal that inhibits fungal cell‑wall synthesis.

- Invasive candidiasis: effective treatment of bloodstream and deep‑seated Candida infections. - Esophageal candidiasis: resolves mucosal Candida infection of the esophagus. - Prophylaxis in hematopoietic stem cell transplantation: prevents Candida infection in high‑risk transplant recipients.

Micafungin may cause a range of adverse reactions.

Common Side Effects: - Fever: transient temperature rise during or after infusion. - Nausea: mild to moderate gastrointestinal discomfort. - Headache: occasional mild headache during therapy. - Infusion‑related reactions: erythema, flushing, or mild hypotension. - Elevated liver enzymes: transient increase in ALT/AST. - Rash: mild skin eruption.

Serious or Rare Side Effects: - Severe hepatic failure: marked elevation of liver enzymes with possible liver injury. - Anaphylaxis: acute, life‑threatening hypersensitivity reaction. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin and mucosal detachment. - Renal impairment: acute kidney injury in susceptible patients. - Severe hypotension: marked drop in blood pressure requiring intervention. - Cardiac arrhythmia: rare rhythm disturbances during infusion.

Use micafungin with careful clinical monitoring.

- Renal function: assess baseline renal parameters and monitor during therapy. - Hepatic function: evaluate liver enzymes before initiating and periodically thereafter. - Concomitant antifungals: avoid co‑administration with agents that share metabolic pathways without specialist advice. - Pregnancy and lactation: prescribe only when the expected benefit justifies potential risk to the fetus or infant. - Storage: Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with several medicines; clinical vigilance is required.

Major Interactions (Avoid): - Cyclosporine: increased micafungin exposure may raise toxicity risk. - Rifampin: strong enzyme induction reduces micafungin plasma levels. - Azole antifungals (e.g., fluconazole): additive toxicity potential.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR; monitor coagulation. - Statins (e.g., simvastatin): monitor for myopathy or rhabdomyolysis. - Immunosuppressants (e.g., tacrolimus): adjust dosing based on therapeutic drug monitoring.